Medical versus medical and surgical treatment for brucella endocarditis

Ann Thorac Surg. 2012 Dec;94(6):2141-6. doi: 10.1016/j.athoracsur.2012.07.006. Epub 2012 Oct 26.

Abstract

This review was undertaken to determine the role of surgery in the treatment of brucella endocarditis. All English and French articles reporting brucella endocarditis (1966 to 2011) in PubMed, Google, and Scopus were reviewed. In all, 308 cases were identified, and linear and logistic regression was performed. Surgery improved outcomes by decreasing mortality from 32.7% in the medical treatment only group to 6.7% in the combined surgical and medical treatment group (p<0.001). This association was still significant while controlling for other contributing factors. In the absence of a controlled trial, we recommend the utmost vigilance and consideration of surgical management in treating such patients.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Brucella / isolation & purification*
  • Brucellosis / microbiology
  • Brucellosis / therapy*
  • Cardiac Surgical Procedures / methods*
  • Endocarditis, Bacterial / microbiology
  • Endocarditis, Bacterial / therapy*
  • Humans
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents